These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2371766)
1. Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron. Mason BB; Davis AR; Bhat BM; Chengalvala M; Lubeck MD; Zandle G; Kostek B; Cholodofsky S; Dheer S; Molnar-Kimber K Virology; 1990 Aug; 177(2):452-61. PubMed ID: 2371766 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs. Chengalvala MV; Bhat BM; Bhat R; Lubeck MD; Mizutani S; Davis AR; Hung PP J Gen Virol; 1994 Jan; 75 ( Pt 1)():125-31. PubMed ID: 8113721 [TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of adenovirus co-expressing hepatitis B virus surface antigen and interleukin-6. Lindley T; Virk KP; Ronchetti-Blume M; Goldberg K; Lee SG; Eichberg JW; Hung PP; Cheng SM Gene; 1994 Jan; 138(1-2):165-70. PubMed ID: 8125296 [TBL] [Abstract][Full Text] [Related]
4. Expression of hepatitis B surface antigen with a recombinant adenovirus. Davis AR; Kostek B; Mason BB; Hsiao CL; Morin J; Dheer SK; Hung PP Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7560-4. PubMed ID: 3865177 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs. Chengalvala M; Lubeck MD; Davis AR; Mizutani S; Molnar-Kimber K; Morin J; Hung PP Vaccine; 1991 Jul; 9(7):485-90. PubMed ID: 1832806 [TBL] [Abstract][Full Text] [Related]
6. High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants. Chanda PK; Natuk RJ; Mason BB; Bhat BM; Greenberg L; Dheer SK; Molnar-Kimber KL; Mizutani S; Lubeck MD; Davis AR Virology; 1990 Apr; 175(2):535-47. PubMed ID: 2183470 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Lubeck MD; Davis AR; Chengalvala M; Natuk RJ; Morin JE; Molnar-Kimber K; Mason BB; Bhat BM; Mizutani S; Hung PP Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6763-7. PubMed ID: 2570422 [TBL] [Abstract][Full Text] [Related]
8. Sequence analysis in the E1 region of adenovirus type 4 DNA. Tokunaga O; Yaegashi T; Lowe J; Dobbs L; Padmanabhan R Virology; 1986 Dec; 155(2):418-33. PubMed ID: 2947381 [TBL] [Abstract][Full Text] [Related]
9. [DNA cloning of Ad7 vaccine strain and sequence analysis of its Sma I H fragment]. Zhou J; Qu J; Shi C Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):23-5. PubMed ID: 12515165 [TBL] [Abstract][Full Text] [Related]
10. Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees. Chengalvala MV; Bhat BM; Bhat RA; Dheer SK; Lubeck MD; Purcell RH; Murthy KK Vaccine; 1997 Feb; 15(3):335-9. PubMed ID: 9139496 [TBL] [Abstract][Full Text] [Related]
11. Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector. Ye WW; Mason BB; Chengalvala M; Cheng SM; Zandle G; Lubeck MD; Lee SG; Mizutani S; Davis AR; Hung PP Arch Virol; 1991; 118(1-2):11-27. PubMed ID: 1828660 [TBL] [Abstract][Full Text] [Related]
12. Sequences of human adenovirus Ad3 and Ad7 DNAs encoding the promoter and first leader segment of late RNAs. Engler JA; Chow LT; Broker TR Gene; 1981 Mar; 13(2):133-43. PubMed ID: 6263757 [TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon. Tian X; Su X; Li H; Li X; Zhou Z; Liu W; Zhou R Virus Res; 2011 Sep; 160(1-2):214-20. PubMed ID: 21740937 [TBL] [Abstract][Full Text] [Related]
14. Physical mapping of the genome and sequence analysis at the inverted terminal repetition of adenovirus type 4 DNA. Tokunaga O; Shinagawa M; Padmanabhan R Gene; 1982 Jun; 18(3):329-34. PubMed ID: 6290336 [TBL] [Abstract][Full Text] [Related]
15. The major late promoter and bipartite leader sequence of fowl adenovirus. Sheppard M; Werner W; McCoy RJ; Johnson MA Arch Virol; 1998; 143(3):537-48. PubMed ID: 9572553 [TBL] [Abstract][Full Text] [Related]
16. Conservation of essential sequences in the major late promoter and tripartite leader of the simian adenovirus type 30. Hsiao CL; Woessner KJ; Cheng SM; Dheer SK; Vince T; Lee SG; Hung PP Gene; 1990 May; 89(2):275-7. PubMed ID: 2165022 [TBL] [Abstract][Full Text] [Related]
17. Expression of HBV surface antigen or HIV envelope protein using recombinant adenovirus vectors. Hung PP; Morin JE; Lubeck MD; Barton JE; Molnar-Kimber KL; Mason BB; Dheer SK; Jarocki-Witek V; Kostek B; Zandle G Nat Immun Cell Growth Regul; 1988; 7(3):135-43. PubMed ID: 3173369 [TBL] [Abstract][Full Text] [Related]
18. Adenovirus early region 4 stimulates mRNA accumulation via 5' introns. Nordqvist K; Akusjärvi G Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9543-7. PubMed ID: 2263609 [TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of adenovirus-associated VA RNAs of human adenovirus type 7. Smith PP; Dheer S; Davis A; Hung PP; Lee SG Gene; 1994 May; 142(2):309-10. PubMed ID: 8194770 [TBL] [Abstract][Full Text] [Related]
20. The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export. Huang W; Flint SJ J Virol; 1998 Jan; 72(1):225-35. PubMed ID: 9420219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]